29 Jul 2022 , 02:43 PM
Net profit of Sun Pharmaceuticals Industries rose 42.70% to Rs 2060.88 crore in the quarter ended June 2022 as against Rs 1444.17 crore during the previous quarter ended June 2021. Sales rose 10.08% to Rs 10643.97 crore in the quarter ended June 2022 as against Rs 9669.43 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 10643.97 | 9669.43 | 10 |
| OPM % | 27.10 | 29.18 | – |
| PBDT | 2872.84 | 2938.51 | -2 |
| PBT | 2284.84 | 2435.29 | -6 |
| NP | 2060.88 | 1444.17 | 43 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
